Military wound dressing for junctional wounds approved for civilian use

XSTAT 30 is a hemostatic device for the treatment of severe bleeding in the axilla or groin area


XSTAT 30, a hemostatic device for the treatment of severe bleeding in the axilla or groin area, was cleared for use in both battlefield and civilian trauma settings by the U.S. Food and Drug Administration.

The clearance expands the device’s indication from use by the military only to use in adults and adolescents in the general population.

XSTAT 30 by RevMedx works by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator.

XSTAT 30 by RevMedx works by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator. (Photo courtesy of RevMedx)
XSTAT 30 by RevMedx works by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator. (Photo courtesy of RevMedx)

In a wound, the sponges expand and swell to fill the wound cavity within 20 seconds of contact with blood. This process creates a temporary barrier to blood flow and provides hemostatic pressure. Each sponge contains an x-ray detectable marker to aid in surgical removal.

Early control of severe bleeding may prevent shock and may be life-saving. The United States Army Institute of Surgical Research reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhaging; of those deaths, 33 to 56 percent occur before the patient reaches an emergency care facility. 

Request product info from top EMS Bleeding Control companies

Thank You!

By submitting your information, you agree to be contacted by the selected vendor(s).

Join the discussion

Copyright © 2019 ems1.com. All rights reserved.